Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-02

Clinical Trial Update: Tranexamic Acid vs. Combination With Fractional Carbon Dioxide Laser in Melasma [Phase 4]

View source ↗

Summary

A phase 4 clinical trial comparing tranexamic acid alone versus tranexamic acid combined with fractional CO2 laser for melasma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fractional CO2 Laser
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Cairo University | Conditions: Melasma | Phase 4 | Status: UNKNOWN